AIM’s Clinical Strategy Under Incumbent Board Has Totally Failed
Go back to AIM’s Clinical Strategy Under Incumbent Board Has Totally Failed| Aerosonic Corp. (NYSE: AIM) | Delayed: 0.23 -0.01 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.24 | 52 Week High | $8.92 | |||
| Open | $0.24 | 52 Week Low | $2.64 | |||
| Day High | $0.26 | P/E | 0.37 | |||
| Day Low | $0.23 | EPS | $0.62 | |||
| Volume | 456,882 | |||||
